Point72 Hong Kong’s Loxo Oncology, Inc LOXO Stock Holding History

Point72 Hong Kong’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3	Closed	-$1K	–	1346
2018 Q2	$1K	Buy	+3	New	+$451	﹤0.01%	862

Other funds holding LOXO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Point72 Hong Kong's LOXO Position: Q3 2018 in Review

Point72 Hong Kong sold out of Loxo Oncology, Inc (LOXO) in Q3 2018, closing a stake of 3 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in LOXO in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 228 funds tracked by Wall St. Rank hold LOXO as of Q3 2018.

Point72 Hong Kong reported no remaining Loxo Oncology, Inc position as of Q3 2018 after selling out during the quarter.
Point72 Hong Kong sold 3 Loxo Oncology, Inc shares in Q3 2018, an estimated $1K.
Point72 Hong Kong first reported a position in Loxo Oncology, Inc in Q2 2018 and held it in 1 quarter.
Point72 Hong Kong's Loxo Oncology, Inc position peaked at $1K in Q2 2018.
228 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2018.

Based on Point72 Hong Kong's 13F filing for Q3 2018, filed 14 Nov 2018.